Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Express Scripts' cost-saving move will slash coverage of 1,000 compounded drugs
Yahoo/AP
Thursday, July 3, 2014 - 10:43am
tags:
compounded drugs, Express Scripts
Pozen Resubmits PA NDA, PDUFA In Two Months?
Seeking Alpha
Thursday, July 3, 2014 - 10:42am
tags:
Pozen, PA8140, PA32540
Regado Halts Big Heart Drug Trial, Shares Hammered
Motley Fool
Thursday, July 3, 2014 - 10:37am
tags:
Regado Biosciences, clinical trials, REG1, anticoagulants
Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions
Seeking Alpha
Thursday, July 3, 2014 - 9:59am
tags:
Pfizer, M&A, Gilead Sciences, AstraZeneca, Celgene
AbbVie presses case for Shire deal in discreet roadshow
Yahoo/Reuters
Thursday, July 3, 2014 - 9:40am
tags:
AbbVie, Shire, M&A
J&J, Oregon Settle in First State Deal Over Hip Implants
Bloomberg
Thursday, July 3, 2014 - 9:36am
tags:
J&J, Oregon, hip implants
Januvia Linked To Increase in Heart Failure Hospitalizations
Forbes
Thursday, July 3, 2014 - 9:35am
tags:
Januvia, heart failure, diabetes, Merck
Roche biotech drug offers new way to fight asthma
Yahoo/Reuters
Wednesday, July 2, 2014 - 4:50pm
tags:
Roche, asthma, quilizumab
Jazz Pharma Buys Out Rights To Newly Acquired Drug
Investors.com
Wednesday, July 2, 2014 - 4:38pm
tags:
Jazz Pharmaceuticals, Defibrotide, Sigma-Tau, Gentium, hepatic veno-occlusive disease
AbbVie CEO visited Shire holders, urged them to pressure company, FT says
The Fly on the Wall
Wednesday, July 2, 2014 - 4:32pm
tags:
Shire, AbbVie, M&A, Richard Gonzalez
Takeda's chief-in-waiting sees big M&A in the drugmaker's future
Fierce Biotech
Wednesday, July 2, 2014 - 1:13pm
tags:
Takeda, M&A, Christophe Weber
$4 Or Less: 2 Small Biotechs Moving On News
Seeking Alpha
Wednesday, July 2, 2014 - 1:12pm
tags:
Pixuvri, Agenus, Cell Therapeutics
Novartis Japan unit faces another criminal charge in data-manipulation scandal
Fierce Pharma
Wednesday, July 2, 2014 - 11:57am
tags:
Novartis, data manipulation, fraud, Japan
Johnson & Johnson Unit Whacks 400 Jobs as Part of Reorganization
WSJ Online
Wednesday, July 2, 2014 - 11:50am
tags:
JNJ, layoffs, reorganization, devices, DePuy
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wednesday, July 2, 2014 - 11:49am
tags:
Alexion, InterMune, FDA, Acadia, Kythera, Intercept Pharmaceuticals, Merrimack Pharmaceuticals, Relypsa, MM-398, patiromer, Esbriet, ATX-101, Soliris, Flint, pimavanserin
Zohydro details timeframe for new Zohydro version
Charlotte Observer, NC
Wednesday, July 2, 2014 - 10:08am
tags:
Zohydro, Zogenix, painkillers
2013's 10 highest-paid Med Tech CEOs
Fierce Medical Devices
Wednesday, July 2, 2014 - 10:07am
tags:
executive pay, devices
FDA says manufacturing issues at St. Jude plant resolved
Yahoo/Reuters
Wednesday, July 2, 2014 - 10:03am
tags:
FDA, St. Jude Medical, devices, drug manufacturing
Why Salix Pharmaceuticals' Good Data Wasn't Great
Motley Fool
Wednesday, July 2, 2014 - 9:57am
tags:
Salix, Xifaxan
Taro Pharmaceuticals: Last Week's Move Is Only The Beginning
Seeking Alpha
Wednesday, July 2, 2014 - 9:56am
tags:
Taro, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.